by Omar Figueroa February 13, 2023 On February 13, 2023, the Drug Enforcement Administration (DEA) clarified the control status under the Controlled Substances Act (CSA) of THC acetate ester (THCO). The DEA concluded that both delta-9-THCO and delta-8-THCO are Schedule I Controlled Substances: The only substances of which the Drug […]
Read More
By Lauren Mendelsohn December 29, 2022 2022 was a significant year for cannabis, hemp, and psychedelics policy in California. We’ve summarized some of the key events below. CANNABIS Legislative Victories in Sacramento A number of cannabis-related bills were adopted in 2022 by the State legislature, which will bring about […]
Read More
by Omar Figueroa December 21, 2022 The Drug Enforcement Administration (DEA) has confirmed that any seed, tissue culture, or other genetic material is not controlled under the Controlled Substances Act (CSA) as long as it has less than 0.3% of delta-9-THC. Specifically, on December 20, 2022, the DEA […]
Read More
By Lauren Mendelsohn October 9, 2022 For the first time ever, cannabis was included – in an addendum – in the annual Sonoma County Crop Report. The county Crop Report is produced each year by the Department of Agriculture, Weights and Measures (“AWM”) and provides a snapshot of local […]
Read More
August 31, 2022 By Lauren Mendelsohn The Food and Drug Branch (FDB) of the California Department of Public Health has issued an Outreach Letter to individuals and businesses interested in the State’s new Industrial Hemp Enrollment and Oversight (IHEO) Authorization for manufacturing hemp products and extracts. (We previously discussed […]
Read More
July 5, 2022 By Lauren Mendelsohn Today, the California Department of Public Health (CDPH) published the application materials for the State’s new Industrial Hemp Enrollment and Oversight authorization (“IHEO authorization”), which is a requirement for manufacturers using industrial hemp (“IH”) or IH-derived ingredients. There are applications to process, manufacture, repack and […]
Read More
By Lauren Mendelsohn April 28, 2022 On April 27, 2022, the California Department of Public Health (“CDPH”) proposed emergency regulations pertaining to industrial hemp manufacturing licensing fees, kicking off a 30-day public comment period. The text of the proposed regulations, which would comprise Sections 23200 through 23235 of Title […]
Read More
By Andrew Kingsdale February 16, 2022 Whether your hemp-related business currently operates in New York or is considering entering that market, two key deadlines approach. First, March 7, 2022 is the last day to submit public comments on certain proposed changes to New York’s cannabinoid hemp regulations. Second, all hemp […]
Read More
By Lauren Mendelsohn December 14, 2021 There is no question that cannabis is a plant which is sown and harvested. Yet the Schedule I status of cannabis under federal law, as well as how it has been defined under California’s Medicinal and Adult Use Cannabis Regulation and Safety Act (MAUCRSA) […]
Read More
By Lauren Mendelsohn October 7, 2021 Yesterday, California Governor Gavin Newsom signed Assembly Bill 45 (AB45), which has big implications for the hemp, CBD, and cannabis industries. The bill, sponsored by Assemblymember Aguiar-Curry, was an urgency measure, meaning it went into effect immediately upon the Governor’s signing. It adds […]
Read More